Terry-Ann Burrell

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
6 years
Director since
2023

6 years of board service in total across 2 boards, counting each seat separately. Longest: Recursion Pharmaceuticals Inc., 3 years.

3 years · Since 2023
2 years · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 1, 2024 Recursion Pharmaceuticals Inc. Grant or award +1,843 — —
Jun 3, 2024 Recursion Pharmaceuticals Inc. Grant or award +13,097 — —
Apr 26, 2024 Beam Therapeutics Inc. Grant or award +12,500 — —
Apr 1, 2024 Beam Therapeutics Inc. Open-market sale −5,446 $32.12 $174,926
Apr 1, 2024 Recursion Pharmaceuticals Inc. Grant or award +1,467 — —
Mar 31, 2024 Beam Therapeutics Inc. Grant or award +27,500 — —
Jul 13, 2023 Recursion Pharmaceuticals Inc. Open-market sale −8,275 $12.59 $104,182
Jul 12, 2023 Recursion Pharmaceuticals Inc. Open-market sale −24,302 $11.25 $273,398
Jul 12, 2023 Recursion Pharmaceuticals Inc. Open-market sale −78,071 $12.15 $948,563
Jul 12, 2023 Recursion Pharmaceuticals Inc. Open-market sale −3,195 $13.18 $42,110
Jul 12, 2023 Recursion Pharmaceuticals Inc. Open-market sale −3,157 $14.08 $44,451
Jun 16, 2023 Recursion Pharmaceuticals Inc. Grant or award +12,612 — —
Apr 4, 2023 Beam Therapeutics Inc. Open-market sale −2,186 $29.09 $63,591
Apr 3, 2023 Beam Therapeutics Inc. Open-market sale −2,454 $30.31 $74,381
Mar 31, 2023 Beam Therapeutics Inc. Grant or award +20,000 — —

Questions about Terry-Ann Burrell

What boards is Terry-Ann Burrell on?

Terry-Ann Burrell sits on the boards of Rapport Therapeutics Inc. and Recursion Pharmaceuticals Inc.

How long has Terry-Ann Burrell served on boards?

Our records show at least 6 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.